Improved nerve visualization to reduce unintended intraoperative nerve injury

Developing a clinical solution to enhance real-time intraoperative visualization of nerves for surgeons

Illuminare Biotechnologies

Illuminare Biotechnologies is a clinical stage biotechnology company focused on intra-operative nerve visualization to reduce the risk of nerve damage. Our proprietary lead candidate, Illuminare-1, is a small molecule with an immediate onset of action and sustained duration of nerve illumination. The IND for Illuminare-1 is currently conducting a first-in-human phase 1 clinical trial in radical prostatectomy at Memorial Sloan Kettering Cancer Center to demonstrate safety and initial efficacy improving visualization of nerves. The company expects to enter Phase 2 in 2024.

Learn More